LGI1 and encephalitis: The group with AEDs withdrawal included 34 patients with anti-NMDAR encephalitis, 1 with anti-LGI1 encephalitis, 1 with anti-GABABR encephalitis, and 1 patient presented coexisting antibodies of anti-LGI1 and CASPR2 (Figure 1).